# 2024-31493: FDA Creates Fast Lane for Robot Drug Factories

2024-31493, Advanced Manufacturing Technologies Designation Program; Guidance for Industry; Availability, is a Federal Register notice from an unnamed agency published 2025-01-02, effective 2025-01-02 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2024-31493
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2024-31493
- Title: Advanced Manufacturing Technologies Designation Program; Guidance for Industry; Availability
- Type: Notice
- Agencies: unknown
- Citation: unknown
- Published: 2025-01-02
- Effective: 2025-01-02
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Creates Fast Lane for Robot Drug Factories

## Summary

The FDA just released new guidance to help drug makers use cool, advanced manufacturing technologies that make medicines safer, faster, and more reliable. This program is perfect for companies making life-saving or hard-to-get drugs, encouraging them to adopt these tech upgrades early. The guidance is effective starting January 2, 2025, and could speed up drug development while keeping important medicines in supply.

## Abstract

The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Advanced Manufacturing Technologies Designation Program." FDA encourages the early adoption of advanced manufacturing technologies (AMTs) by the pharmaceutical industry, which can improve the reliability and robustness of the manufacturing process and can benefit patients by enhancing product quality and reducing drug development time or increasing or maintaining the supply of drugs that are life-supporting, life-sustaining, of critical importance to providing health care, or in shortage. This guidance provides recommendations to persons and organizations interested in participating in FDA's Advanced Manufacturing Technologies Designation Program, which facilitates the development of drugs manufactured using an AMT that has been designated as such under the program. The guidance finalizes the draft guidance of the same title issued on December 13, 2023.

## Effects PRIA read

- Faster FDA help for drug makers: benefit, high. Under section 506L of the Federal Food, Drug, and Cosmetic Act, FDA's Advanced Manufacturing Technologies Designation Program lets applicants reference a designated advanced manufacturing technology (AMT) in a drug application and receive benefits such as FDA's early interaction about development a…
- Clear rules on AMT designation requests: benefit, medium. The guidance explains eligibility criteria, what data and information to submit, and the assessment process for requesting AMT designation. The final guidance (published January 2, 2025) also includes questions-and-answers and clarifications from the December 13, 2023 draft.
- Potential improved supply and quality of critical drugs: benefit, high. FDA says AMTs can improve manufacturing reliability and product quality, reduce drug development time, and help increase or maintain supply of drugs that are life-supporting, life-sustaining, critically important, or in shortage. The guidance is final as of the Federal Register notice on January 2,…

## Related documents

- [2026-20724](https://policyrisk.com/federal-register/2026-20724): Notice of Intent To Prepare a Supplemental Environmental Impact Statement for the Sentinel Deployment and Minuteman III Decommissioning and…, 2026-10-09
- [2026-20771](https://policyrisk.com/federal-register/2026-20771): Center for Scientific Review; Notice of Closed Meetings, 2026-10-09
- [2026-20708](https://policyrisk.com/federal-register/2026-20708): Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX…, 2026-10-09
- [2026-20710](https://policyrisk.com/federal-register/2026-20710): Self-Regulatory Organizations; Investors Exchange LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Change Pursuant to IEX…, 2026-10-09
- [2026-20779](https://policyrisk.com/federal-register/2026-20779): Passenger Vehicle and Light Truck Tires From Thailand: Preliminary Results and Rescission, in Part, of Antidumping Duty Administrative Revi…, 2026-10-09
- [2026-20763](https://policyrisk.com/federal-register/2026-20763): National Environmental Policy Act Implementing Procedures: Wintertime Oil and Gas Exploration in the National Petroleum Reserve in Alaska C…, 2026-10-09

## Sources
- [2024-31493 on federalregister.gov](https://www.federalregister.gov/documents/2025/01/02/2024-31493/advanced-manufacturing-technologies-designation-program-guidance-for-industry-availability)
- [2024-31493 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-01-02/pdf/2024-31493.pdf)

## Related
- [Previous: 2024-31491, Transportation and Climate Division (TCD) Grant Program Reporting Templates: Su…](https://policyrisk.com/federal-register/2024-31491)
- [Next: 2024-31496, Roster of Arbitrators-Annual Update](https://policyrisk.com/federal-register/2024-31496)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2024-31493 (as of 2026-06-08).